NCT07598396

A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2026-05-25Est. Completion: 2028-02-28

Enrollment target: 30 participants

Locations

Clnica SER da Bahia, Salvador, Estado de Bahia, Brazil
L2IP ?Instituto de Pesquisas Clínicas Ltda., Brasília, Federal District, Brazil
IPC MT Instituto de Pesquisas Clinicas do Mato Grosso, Cuiab, Mato Grosso, Brazil
Complexo Hospitalar de Niteroi, Niterói, Rio de Janeiro, Brazil
LMK Servios Mdicos S/S Ltda, Porto Alegre, Rio Grande do Sul, Brazil
Hospital das Clinicas de Ribeirao Preto, Ribeiro Preto, São Paulo, Brazil
Hospital das Clnicas da Faculdade de Medicina da USP, São Paulo, São Paulo, Brazil
Clinica de la Costa S.A.S, Barranquilla, Colombia
Centro de Investigacion en Reumatologia y Especialdades Medicas SAS. CIREEM, Bogotá, Colombia
Hospital Pablo Tobon Uribe, Medellín, Colombia
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Lazio, Italy
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (Presidio Spedali Civili), Brescia, Lombardy, Italy
Centro Medico del Angel, Mexicali, Estado de Baja California, Mexico
Centro de Investigación y Tratamiento Reumatológico S.C., México, Mexico CITY (federal District), Mexico

Systemic Lupus Erythematosus

The purpose of this study is evaluating the efficacy and safety of SC antifrolumab in adult patients with moderate -to-s…

Birmingham, United StatesEst. completion Aug 22, 2025

Systemic Lupus Erythematosus (SLE)

In this study, researchers will learn more about a study drug called litifilimab (BIIB059) in participants with systemic…

Phoenix, United StatesCompleted Mar 29, 2030

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.